Efficacy analyses were performed on two sets: the full analysis set, defined as all unique randomized patients grouped according to the treatment assigned at randomization, thereby following the intent-to-treat principle, and an on-treatment analysis, defined as all exposed patients while they were receiving treatment (that is, had received at least one dose in the previous 35 d), grouped according to the treatment that they received
For example, medications affecting liver metabolism or blood-thinning drugs may require adjustments or closer monitoring during treatment
Medicare to Cover GLP-1 Medications for Obesity Starting July 2026 Starting July 2026, Medicare will cover GLP-1 medications for obesity for the first time under the Medicare GLP-1 Bridge program, announced in December 2025
Vitamin A and vitamin E are available as OTC supplements
Ryoo, E.-K
Wang H, Xu H, Dyck LE, Li XM